Clinical trial
Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases
NCT05859997
Study timeline
Study start (actual)2023-05-17Date precision: day
Registry last updated2024-11-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Systemic Lupus Erythematosus (SLE)unresolved
Sjogren's Syndromeunresolved
Systemic Sclerosisunresolved
Inflammatory Myopathyunresolved
ANCA Associated Systemic Vasculitisunresolved
Antiphospholipid Syndromeunresolved
Interventions
BRL-301BIOLOGICAL
Sponsors & collaborators
Bioray Laboratorieslead sponsor
Shanghai Changzheng Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05859997 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.